Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | tachykinin receptor 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | ko:K04224 tachykinin receptor 3, putative | Get druggable targets OG5_137770 | All targets in OG5_137770 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium leprae | PROBABLE 3-ISOPROPYLMALATE DEHYDROGENASE LEUB (BETA-IPM DEHYDROGENASE) (IMDH) (3-IPM-DH) | 0.0045 | 0.0053 | 0.5 |
Echinococcus granulosus | isocitrate dehydrogenase NAD subunit | 0.0045 | 0.0053 | 0.0053 |
Schistosoma mansoni | tar DNA-binding protein | 0.0058 | 0.0273 | 0.0273 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.037 | 0.5572 | 0.5572 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.037 | 0.5572 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0051 | 0.0157 | 0.0282 |
Schistosoma mansoni | tar DNA-binding protein | 0.0058 | 0.0273 | 0.0273 |
Schistosoma mansoni | unc-13 (munc13) | 0.0045 | 0.0053 | 0.0053 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.037 | 0.5572 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0058 | 0.0273 | 0.049 |
Schistosoma mansoni | Isocitrate dehydrogenase [NAD] subunit gamma mitochondrial | 0.0045 | 0.0053 | 0.0053 |
Schistosoma mansoni | tar DNA-binding protein | 0.0058 | 0.0273 | 0.0273 |
Schistosoma mansoni | tar DNA-binding protein | 0.0058 | 0.0273 | 0.0273 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.037 | 0.5572 | 0.5572 |
Entamoeba histolytica | tartrate dehydrogenase, putative | 0.0045 | 0.0053 | 0.5 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0631 | 1 | 1 |
Echinococcus multilocularis | isocitrate dehydrogenase (NAD) subunit | 0.0045 | 0.0053 | 0.0053 |
Brugia malayi | isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial | 0.0045 | 0.0053 | 0.0095 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.037 | 0.5572 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0051 | 0.0157 | 0.0282 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.037 | 0.5572 | 0.5572 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.037 | 0.5572 | 0.5 |
Brugia malayi | Isocitrate dehydrogenase subunit gamma, mitochondrial precursor | 0.0045 | 0.0053 | 0.0095 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.037 | 0.5572 | 0.5572 |
Brugia malayi | isocitrate dehydrogenase [NAD] subunit beta, mitochondrial | 0.0045 | 0.0053 | 0.0095 |
Brugia malayi | Probable isocitrate dehydrogenase | 0.0045 | 0.0053 | 0.0095 |
Brugia malayi | isocitrate dehydrogenase | 0.037 | 0.5572 | 1 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.037 | 0.5572 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0058 | 0.0273 | 0.049 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.037 | 0.5572 | 1 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0631 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0045 | 0.0053 | 0.0095 |
Brugia malayi | Isocitrate dehydrogenase | 0.037 | 0.5572 | 1 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.037 | 0.5572 | 0.5 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.037 | 0.5572 | 1 |
Wolbachia endosymbiont of Brugia malayi | isocitrate dehydrogenase | 0.0045 | 0.0053 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0058 | 0.0273 | 0.049 |
Schistosoma mansoni | isocitrate dehydrogenase | 0.0045 | 0.0053 | 0.0053 |
Loa Loa (eye worm) | isocitrate dehydrogenase gamma subunit | 0.0045 | 0.0053 | 0.0095 |
Loa Loa (eye worm) | TAR-binding protein | 0.0058 | 0.0273 | 0.049 |
Echinococcus multilocularis | isocitrate dehydrogenase (NAD+) | 0.0045 | 0.0053 | 0.0053 |
Trichomonas vaginalis | isocitrate dehydrogenase, putative | 0.0045 | 0.0053 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0058 | 0.0273 | 0.0273 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.037 | 0.5572 | 0.5572 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.037 | 0.5572 | 0.5572 |
Echinococcus granulosus | isocitrate dehydrogenase NAD | 0.0045 | 0.0053 | 0.0053 |
Loa Loa (eye worm) | RNA binding protein | 0.0058 | 0.0273 | 0.049 |
Echinococcus granulosus | tar DNA binding protein | 0.0058 | 0.0273 | 0.0273 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.037 | 0.5572 | 0.5572 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.037 | 0.5572 | 1 |
Brugia malayi | RNA binding protein | 0.0058 | 0.0273 | 0.049 |
Mycobacterium ulcerans | 3-isopropylmalate dehydrogenase | 0.0045 | 0.0053 | 0.5 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.037 | 0.5572 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0058 | 0.0273 | 0.0273 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.037 | 0.5572 | 0.5 |
Brugia malayi | Probable isocitrate dehydrogenase | 0.0045 | 0.0053 | 0.0095 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 27 nM | Binding affinity against NK1 receptor by displacement of [3H]-SP from bovine retina membranes | ChEMBL. | No reference |
IC50 (binding) | = 27 nM | Binding affinity against NK1 receptor by displacement of [3H]-SP from bovine retina membranes | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.